Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Single monoclonal antibody infusion can strengthen the body's fight against yellow fever

Single monoclonal antibody infusion can strengthen the body's fight against yellow fever

New class of oral drugs inhibits a diverse range of SARS-CoV-2 strains

New class of oral drugs inhibits a diverse range of SARS-CoV-2 strains

New model, C. elegans, helps pursue research on Parkinson's disease

New model, C. elegans, helps pursue research on Parkinson's disease

Herpesvirus infection boosts host cellular immunity: Study

Herpesvirus infection boosts host cellular immunity: Study

Prototype treatment shows great potential in neutralizing snake toxins from multiple species

Prototype treatment shows great potential in neutralizing snake toxins from multiple species

Study shows how convalescent plasma can be used as effective treatment during future pandemics

Study shows how convalescent plasma can be used as effective treatment during future pandemics

Adding antioxidants to cell cultures for efficient production of antibodies

Adding antioxidants to cell cultures for efficient production of antibodies

UC San Diego Alpha Clinic awarded $8 million to bring new stem cell-based therapies to patients

UC San Diego Alpha Clinic awarded $8 million to bring new stem cell-based therapies to patients

New technique could help fine-tune the production of useful proteins

New technique could help fine-tune the production of useful proteins

Researchers work on DNA-delivered antibodies to stop COVID-19

Researchers work on DNA-delivered antibodies to stop COVID-19

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

Spirea raises £2.4M ($3M) to develop antibody drug conjugates   in cancer

Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

Human nose organoids reveal the first events of SARS-CoV-2 and RSV infection

Human nose organoids reveal the first events of SARS-CoV-2 and RSV infection

Single-cell sequencing technique helps to examine early SARS-CoV-2 infection

Single-cell sequencing technique helps to examine early SARS-CoV-2 infection

A folic acid-like drug changes a DNA process within brain tumors

A folic acid-like drug changes a DNA process within brain tumors

Duke engineers develop a rapid test to identify antibody effectiveness against COVID-19 variants

Duke engineers develop a rapid test to identify antibody effectiveness against COVID-19 variants

Study finds amphipathic peptide that safely opens endosomal membrane

Study finds amphipathic peptide that safely opens endosomal membrane

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Experts develop antibodies that effectively remove senescent cells

Experts develop antibodies that effectively remove senescent cells